THE 5-SECOND TRICK FOR EXCIPIENTS AND APIS

“The present situation has exposed some structural weaknesses during the EU’s medicines offer chain and also a significant dependence on non-EU countries for active pharmaceutical ingredients,” Kyriakides explained. She recommended that offer chain concerns be addressed in an EU pharmaceutical approach predicted for being launched by the top